The first guest lineup is released! The first vaccine event in 2023 has set off another boom in new vaccine research and development!

The outbreak of the new crown epidemic has raised people's attention to vaccines to an unprecedented height, and with the continuous strengthening and improvement of global human health awareness, the entire vaccine market size has also expanded
rapidly 。 Therefore, on January 6-7, 2023, the 5th VacCon2023 New Vaccine R&D and Industrialization Forum will be brilliantly unveiled in Wuhan! 4 special sessions and 13 topics, 60+ experts from government regulatory agencies, scientific research experts, scientists and leaders of leading enterprises in the field of new vaccines, starting from domestic and foreign supervision, hot research and development, advanced technology, production quality control and other dimensions, brought human/veterinary pets/nucleic acid/other new vaccines (new adjuvant and recombinant protein vaccines, viral vectors and mucosal vaccines, broad-spectrum/polyvalent/multi-vaccine vaccines, etc.
) and other cutting-edge innovative technology applications and cases, to help China's vaccine industry develop at full speed!

【Free Attendance】

Click the link to receive a free ticket: _istranslated="1"> (only available to research institutions/vaccine, pharmaceutical R&D and manufacturing enterprises)

[The first batch of blockbuster speakers are the first to watch! ] 】

Gao Guang, Senior Technical Officer of PATH, former Chief Reviewer and Inspector of the US
FDA Center for Biological Products Jiang Shibo, Director of the Institute of Pathogenic Microbiology of Fudan University, Academician
of the American Academy of Microbiology
Xia Ningshao, Professor Li Yuhua, School of Life Sciences/School of Public Health, Xiamen University, Director of Arbovirus Vaccine Office, China Institute of Food and Drug Control (under confirmation)
Lu Jiahai, Professor of School of Public Health, Sun Yat-sen University / Director of
the Key Laboratory of Quality Monitoring and Evaluation of Vaccines and Biological Products of the State Medical Products Administration of YingBev, Founder & CEO of Suzhou Aybogen Biotechnology Co.
, Ltd.
Wu Ke, Founder and CEO of Bowo Biotechnology, Jin Xia, Distinguished Industrial Professor
of Hubei Provincial Government, CEO
and Co-founder of Yike Biotechnology
Liao Yuhua, General Manager of Wuhan Huajiyuan Biotechnology Development Co.
, Ltd.
,
Zheng Haifa, Second-level Professor of Cardiology of Wuhan Union Medical College Hospital, Cheng Ke, Vice Chairman, Vice President and Chief Scientist of Kangtai Biotechnology, General Manager
of Minhai Biotechnology Co.
, Ltd.
, Chen Ling, Founder of Xsome Biotech and Chair Professor
of North Carolina State University, Yan Huimin, Nanshan Scholar Distinguished Professor of State Key Laboratory of Respiratory Diseases of Guangzhou Medical University and Distinguished Researcher of Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Yi Yinglei, Researcher
of Shanghai Public Health Clinical Center (affiliated to Fudan University), Nie Guangjun, Head of Infectious Disease Pipeline of

Siwei (Shanghai) Biotechnology Co.
, Ltd.
, and researcher of National Nanoscience Center
Jia Weiguo, Funuojian/Zhongsheng Funuojian, Chief Scientist
Wang Yucai, Professor of University of Science and Technology of China, founder and chairman
of Hefei Afana Biotechnology Co.
, Ltd.
Wang Zefeng, researcher of Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Lan Zhanghua, scientific consultant
of Huanma Biomedical Science, Hu Yong, Deputy General Manager
of China Cell Biotechnology Group Co.
, Ltd , Gao Lu, Founder, Chairman and General Manager
of St.
Regis Biologics, Lu Hang, CEO of Yuanyin (Beijing) Biotechnology Co.
, Ltd.
, Yang Beibei, Founder and CEO

of Jiayi Biomedical (Hangzhou) Co.
, Ltd.
, Yuan Wei, Director of the Vaccine Clinical Evaluation Center of Hubei Center for Disease Control and Prevention, and China National Representative of
PATH
Xiao Jin, Zhongmu Research Institute, Vice President Wu Wenfu, Senior Veterinarian, Fang Zhizheng, Senior Expert
of Swine Vaccines of Guangdong Yongshun Biopharmaceutical Co.
, Ltd.
, Song Gengshen, Deputy General Manager of Wuhan Binhui Biotechnology Co.
, Ltd.
, Song Jiasheng, Deputy General Manager
and President

of Yuekang Pharmaceutical, Zhejiang Difurunsi Biotechnology Co.
, Ltd.
Founder
Wang Qihui, researcher of the Institute of Microbiology, Chinese Academy of Sciences
, Chen Sidi, associate professor
of Yale University School of Medicine.
.
.
*The above updates are as of November 15, and more heavyweight guest lineups will continue to be updated! For the latest agenda information and guest lineup, please contact the organizing committee: 177 2112 0767 (same as WeChat)

[Focus on cutting-edge |.
] Highlights】

1.
Not only new crown vaccines, but also explore the R&D challenges and breakthroughs of various infectious diseases, tumors and other large varieties of new vaccines under the new technical route of rapid rise of new crown
vaccines2.
Obtain the most cutting-edge new vaccines (new adjuvant recombinant proteins, viral vector mucosal vaccines, broad-spectrum/polyvalent/multi-vaccine development) and CMC progress3
.
In-depth discussion on the upgrading and innovation of mRNA and circular RNA technology, Find the best solutions
for mRNA vaccine CMC process production, quality control, industrial chain construction, etc.
4, cope with the challenges of China's vaccines going overseas in the future, learn ICH vaccine supervision and regulatory requirements, improve the vaccine production quality standard system in line with international standards and learn the leading practice
of technology transfer5.
Explore the huge market potential of veterinary pet vaccines, explore the research and development and application of new technologies in veterinary vaccines, and break the challenges of new vaccine research and development such as African swine fever vaccine

【New upgrade | Conference Structure】

【Exhibition/Forum Organization Work Fully Launched】

1.
A variety of cooperation forms are hot and open!
Keynote speeches, product displays, interstitial advertisements, dinner sponsorship, ropes & name cards, handbags, bottled water, chair cover advertisements and other forms of cooperation are hotly open! Limited quota, for details: 180 1793 9885 (same as WeChat)

2.
VacCon2023 speakers are hot!
Speech abstract/paper submission, guests who have been evaluated and confirmed by the organizing committee will enjoy the following benefits:
▪ Receive a free full participation card;
▪ Lunch coupons, guest reception dinners during the conference;
▪ Exclusive guest lounge for speakers during the conference;
▪ Official publicity and promotion
of the organizing committee.

Submission email: vaccon@bmapglobal.
com

【Free Attendance】

Click the link to receive a free ticket: _istranslated="1"> (only available to research institutions/vaccine, pharmaceutical R&D and manufacturing enterprises)

For details of sponsorship/speech/participation/media cooperation, please contact the organizing committee: Tel: 177 2112 0767 (same as WeChat)
E-mail: vaccon@bmapglobal.
com
Website:
www.
bmapglobal.
com/vaccon2023

Media cooperation contact:
Zhao Junwen of Shanghai Shangtu Information Consulting Co.
, Ltd
.
| Jane Zhao
Tel:+86 136 6556 4971
Official Website: www.
bmapglobal.
com